Phase I/II trial of cisplatin (CDDP), etoposide (ETP), and irinotecan (CPT-11) for the treatment of advanced non-small-cell lung cancer (NSCLC). Japan Clinical Oncology Group (JCOG) study 9512

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 23
Author(s):  
M Makino ◽  
H Tsukada ◽  
A Yokoyama ◽  
Y Kurita ◽  
H Isobe ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document